Paracor Surgical Inc. completed its second-round venture financing June 25. The round brought in $16 million.
Pequot Ventures and InterWest Partners led the round. Other investors included De Novo Ventures and RWI Group.
Sunnyvale-based Paracor Surgical creates treatments for congestive heart failure. It has created a product...
Pequot Ventures and InterWest Partners led the round. Other investors included De Novo Ventures and RWI Group.
Sunnyvale-based Paracor Surgical creates treatments for congestive heart failure. It has created a product...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In